Northern Trust’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Buy
+14,903
New +$11.5K ﹤0.01% 4412
2023
Q2
Sell
-201
Closed -$14.1K 4592
2023
Q1
$14.1K Hold
201
﹤0.01% 4491
2022
Q4
$16.5K Hold
201
﹤0.01% 4520
2022
Q3
$16K Hold
201
﹤0.01% 4585
2022
Q2
$32K Hold
201
﹤0.01% 4538
2022
Q1
$75K Hold
201
﹤0.01% 4435
2021
Q4
$78K Hold
201
﹤0.01% 4492
2021
Q3
$151K Sell
201
-3
-1% -$2.51K ﹤0.01% 4278
2021
Q2
$213K Hold
204
﹤0.01% 4143
2021
Q1
$305K Buy
204
+2
+1% +$2.91K ﹤0.01% 3977
2020
Q4
$214K Buy
202
+1
+0.5% +$909 ﹤0.01% 3944
2020
Q3
$145K Sell
201
-56
-22% -$53.4K ﹤0.01% 3878
2020
Q2
$177K Sell
257
-717
-74% -$322K ﹤0.01% 3791
2020
Q1
$327K Buy
974
+617
+173% +$243K ﹤0.01% 3552
2019
Q4
$290K Buy
357
+15
+4% +$18K ﹤0.01% 3685
2019
Q3
$488K Buy
342
+251
+276% +$402K ﹤0.01% 3543
2019
Q2
$194K Buy
91
+19
+26% +$38.6K ﹤0.01% 3833
2019
Q1
$115K Buy
+72
New +$113K ﹤0.01% 3896

Other funds holding YCBD

Northern Trust's YCBD Position: Q2 2026 in Review

Northern Trust opened a new position in cbdMD (YCBD) in Q2 2026: 14,903 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #4412 among its holdings. This is a return to the name: Northern Trust previously reported a position in YCBD as recently as Q1 2023.

Northern Trust first reported a position in YCBD in Q1 2019 and has held it in 18 quarters since. The position peaked at $488K in Q3 2019. 27 funds tracked by Wall St. Rank hold YCBD as of Q2 2026.

  • Northern Trust held 14,903 shares of cbdMD worth $10K as of Q2 2026.
  • cbdMD was a new Northern Trust position in Q2 2026.
  • cbdMD made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4412 holding.
  • Northern Trust first reported a position in cbdMD in Q1 2019 and has held it in 18 quarters since.
  • Northern Trust's cbdMD position peaked at $488K in Q3 2019.
  • 27 funds tracked by Wall St. Rank held cbdMD as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.